Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 142 of the 143 references it cites were found in a registry or an index.

The complex link between NAFLD and type 2 diabetes mellitus - mechanisms and treatments

Targher, Giovanni, Corey, Kathleen E., Byrne, Christopher D., Roden, Michael · 2021 · Nature Reviews Gastroenterology & Hepatology

Abstract

Nonalcoholic fatty liver disease (NAFLD) has reached epidemic proportions worldwide. NAFLD and type 2 diabetes mellitus (T2DM) are known to frequently coexist and act synergistically to increase the risk of adverse (hepatic and extra-hepatic) clinical outcomes. T2DM is also one of the strongest risk factors for the faster progression of NAFLD to nonalcoholic steatohepatitis, advanced fibrosis or cirrhosis. However, the link between NAFLD and T2DM is more complex than previously believed. Strong evidence indicates that NAFLD is associated with an approximate twofold higher risk of developing T2DM, irrespective of obesity and other common metabolic risk factors. This risk parallels the severity of NAFLD, such that patients with more advanced stages of liver fibrosis are at increased risk of incident T2DM. In addition, the improvement or resolution of NAFLD (on ultrasonography) is associated with a reduction of T2DM risk, adding weight to causality and suggesting that liver-focused treatments might reduce the risk of developing T2DM. This Review describes the evidence of an association and causal link between NAFLD and T2DM, discusses the putative pathophysiological mechanisms linking NAFLD to T2DM and summarizes the current pharmacological treatments for NAFLD or T2DM that might benefit or adversely affect the risk of T2DM or NAFLD progression.

Overview

Integrity signals

Registry

Crossref · 10.1038/s41575-021-00448-y

Cites

142 of 142 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 143 references

Cited by

See all 884

Metadata

Authors
Targher, G., Corey, K. E., Byrne, C. D., & Roden, M.
Affiliations
  • University of Verona (IT)
  • Harvard University (US)
  • Southampton General Hospital (GB)
  • Deutsches Diabetes-Zentrum e.V. (DE)
Corresponding author
Targher, Giovanni
Venue
Nature Reviews Gastroenterology & Hepatology
Published
2021-05-10
Volume
18
Issue
9
Pages
599-612
ISSN
  • 1759-5045 (ISSN-L)
  • 1759-5053
OpenAlex
W3160407865
Cited by
850
References
143
Citations by year
2026: 128 · 2025: 188 · 2024: 195 · 2023: 178 · 2022: 134 · 2021: 27
FWCI
20.66
Type
journal article
Language
en
Open access
closed
Licence
Locations
  • Nature Reviews Gastroenterology & Hepatology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
Keywords
non-alcoholic fatty liver disease, type 2 diabetes, pathophysiological mechanisms, liver fibrosis, nonalcoholic steatohepatitis, liver cirrhosis, pharmacotherapy, drug-induced liver injury, insulin resistance
MeSH terms
Diabetes Mellitus, Type 2, Humans, Non-alcoholic Fatty Liver Disease

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The complex link between NAFLD and type 2 diabetes mellitus - mechanisms and treatments. https://app.cochat.ai/papers/10.1038/s41575-021-00448-y
The paper
Targher, G., Corey, K. E., Byrne, C. D., & Roden, M. (2021). The complex link between NAFLD and type 2 diabetes mellitus - mechanisms and treatments. Nature Reviews Gastroenterology & Hepatology. https://doi.org/10.1038/s41575-021-00448-y

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.